Predictors of sputum culture conversion among patients with tuberculosis in the era of tuberculosis resurgence

被引:32
作者
Liu, ZY
Shilkret, KL
Ellis, HM
机构
[1] New Jersey Dept Hlth & Senior Serv, Div Communicable Dis, Trenton, NJ 08625 USA
[2] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
D O I
10.1001/archinte.159.10.1110
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Sputum culture conversion among patients with tuberculosis (TB) is the most important indicator for the effectiveness of treatment and the infectivity of the disease. We sought to investigate predictors for documented sputum culture conversion among TB cases reported in the surveillance system. Methods: This study included 780 patients with pulmonary TB who were initially sputum culture positive in New Jersey in 1994-1995. These patients were followed up for at least 1 week and up to 1 year. Kaplan-Meier curves and Cox proportional hazards models were performed to analyze the data. Results: Overall, 469 (60.1%) of the 780 patients had documented sputum culture conversion. The elderly (36%) and non-Hispanic whites (41.3%) were the least likely to have documented sputum conversion. Patients who were initially given 4 or more drugs were 36% more likely to have documented sputum conversion than those who were initially given fewer than 4 drugs, after adjusting for other factors. Patients who were under the care of chest clinics and the model TB center were about 3 times more likely to have documented sputum conversion than those under care of private physicians. Sex, recurrent TB, foreign-born status, homelessness, injecting drug use, human immunodeficiency virus infection and drug-resistant TB were not significantly associated with the documentation of sputum culture conversion. Conclusions: A substantial proportion of sputum culture-positive TB patients have no documented sputum culture conversion. The type of care provider was the predominant determinant for the documentation of sputum culture conversion.
引用
收藏
页码:1110 / 1116
页数:7
相关论文
共 26 条
[1]  
[Anonymous], 1995, MMWR Recomm Rep, V44, P1
[2]  
[Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
[3]  
[Anonymous], MMWR RECOMM REP
[4]   TREATMENT OF TUBERCULOSIS AND TUBERCULOSIS INFECTION IN ADULTS AND CHILDREN [J].
BASS, JB ;
FARER, LS ;
HOPEWELL, PC ;
OBRIEN, R ;
JACOBS, RF ;
RUBEN, F ;
SNIDER, DE ;
THORNTON, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (05) :1359-1374
[5]   NATIONWIDE SURVEY OF DRUG-RESISTANT TUBERCULOSIS IN THE UNITED-STATES [J].
BLOCH, AB ;
CAUTHEN, GM ;
ONORATO, IM ;
DANSBURY, KG ;
KELLY, GD ;
DRIVER, CR ;
SNIDER, DE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09) :665-671
[6]  
Bloch AB, 1996, PUBLIC HEALTH REP, V111, P26
[7]   RESURGENT TUBERCULOSIS IN NEW-YORK-CITY - HUMAN-IMMUNODEFICIENCY-VIRUS, HOMELESSNESS, AND THE DECLINE OF TUBERCULOSIS-CONTROL PROGRAMS [J].
BRUDNEY, K ;
DOBKIN, J .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (04) :745-749
[8]   NATIONAL TRENDS IN THE CONCURRENCE OF TUBERCULOSIS AND ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
BURWEN, DR ;
BLOCH, AB ;
GRIFFIN, LD ;
CIESIELSKI, CA ;
STERN, HA ;
ONORATO, IM .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (12) :1281-1286
[9]   EPIDEMIOLOGY OF TUBERCULOSIS IN THE UNITED-STATES, 1985 THROUGH 1992 [J].
CANTWELL, MF ;
SNIDER, DE ;
CAUTHEN, GM ;
ONORATO, IM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (07) :535-539
[10]  
*CDC, 1990, MMWR-MORBID MORTAL W, V39, P39